Search & Analyze
Popular Searches
Glaxosmithkline Pharmaceuticals Ltd.
Healthcare₹2,516.050.88%
24 Jul, 4:01 PM
CMP₹2,516.05
Mkt Cap₹42.25K Cr
P/E40.79
P/B18.51
ROE48.76%
52W High₹3,217.10
52W Low₹2,088.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
40.79
P/B Ratio
18.51
EV/EBITDA
28.09
Price/Sales
11.06
Dividend Yield (%)
2.29
EPS (TTM ₹)
61.15
Book Value (₹)
134.77
ROE (%)
48.76
ROCE (%)
66.79
ROA (%)
25.40
EBITDA Margin (%)
31.01
Net Profit Margin (%)
24.54
Debt/Equity
0.00
Current Ratio
2.03
Interest Coverage
515.59
Asset Turnover
1.04
Working Capital/Sales
2.31
Core EBITDA Growth (%)
9.92
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 327802.92 | 325172.3 | 345370.62 | 374921.04 | 382167.47 |
| Net Sales | 327802.92 | 325172.3 | 345370.62 | 374921.04 | 382167.47 |
| Total Income | 335380.48 | 335238.4 | 357629.99 | 389513.99 | 396703.48 |
| Total Expenditure | 251615.12 | 244743.67 | 254501.83 | 257184.72 | 251247.05 |
| Operating Profit | 83765.36 | 90494.73 | 103128.16 | 132329.27 | 145456.43 |
| Depreciation | 6818.6 | 6576.72 | 6967.96 | 6679.25 | 6644.41 |
| Exceptional Items | 1157.66 | -96.79 | -14361.54 | 469.19 | 2062.51 |
| Profit Before Tax | 77904.81 | 83640 | 81618.79 | 125987.84 | 140601.3 |
| Tax | 39827.92 | 22875.78 | 22622.69 | 33229.55 | 37003.06 |
| Profit After Tax (PAT) | 38076.89 | 60764.22 | 58996.1 | 92758.29 | 103598.24 |
| EPS (₹) | 100.04 | 36.05 | 34.83 | 54.76 | 61.15 |
| Dividend Payout % | 900 | 320 | 320 | 540 | 570 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 16940.6 | 16940.6 | 16940.6 | 16940.6 | 16940.6 |
| Reserves | 249354.98 | 157354.42 | 161723.9 | 179678.02 | 211371.89 |
| Shareholders Funds | 266295.58 | 174127.3 | 177763.97 | 195131.07 | 226741.71 |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 452012.97 | 319303.88 | 341030.53 | 396719.94 | 419002.04 |
| Total Assets | 452012.97 | 319303.88 | 341030.53 | 396719.94 | 419002.04 |
| Book Value / Share | 157.1937 | 102.886 | 105.4653 | 116.0636 | 134.7724 |
| Assets | 452012.97 | 319303.88 | 341030.53 | 396719.94 | 419002.04 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 81074.78 | 48422.54 | 58201.55 | 128989.74 | 90329.96 |
| Investing Activities | -40550.76 | 80785.14 | 871.17 | -4580.07 | 39698.17 |
| Financing Activities | -52424.23 | -154332.3 | -56149.69 | -76942.02 | -73707.84 |
| Net Cash Flow | -11900.21 | -25124.62 | 2923.03 | 47467.65 | 56320.29 |
GLAXO
₹2,516.05
+0.88%